- Tech News & Insight
- November 16, 2025
- Hema Kadia
Group revenue reached about €28.9 billion, up 3.3% on an organic basis, with service revenue and adjusted EBITDA AL growing despite currency pressure from a weaker U.S. dollar; adjusted EBITDA AL was roughly €11.1 billion on an organic basis, and full-year 2025 EBITDA AL guidance rose to around €45.3 billion alongside a stronger free cash flow after leases outlook near €20.1 billion. Adjusted net profit increased to approximately €2.7 billion (+14% year-on-year), while reported net profit was €2.4 billion (-18% year-on-year) due to lapping prior-year one-offs in financial activities—an accounting effect rather than a signal of operating weakness.

